Market access, pricing and reimbursement in an uncertain future
A Viewpoint by David Pruce, Practice Lead of Strategic Market Access at Amaris Consulting. Pricing and reimbursement has long been recognized as the fourth hurdle of pharmaceutical development. Even before the COVID pandemic, the environment […]